Table 4 List of 35 adverse events (AE) with relative reporting frequency (RRF) percentage changes ≥ 200% between 2020 and 2021; with the number of signals of disproportionate reporting (SDR) identified by using the total number of unique reports (NRTotal) up to 31/Dec/2021 and by excluding reports solely registering COVID-19 vaccines (NRwoVAC) for VigiBase, FAERS and JADER and the percentage of signals masked by COVID-19 vaccines when considering all reports.

From: Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events

AE

% change of the RRF between, 2020–2021

Number of drugs with disproportionally reported event (PRR ≥ 2, Chi square ≥ 4, and number of individual cases ≥ 3)

Percentage of SDRs masked when considering all reports

Average masking ratio (MR)

NRtotal

NRwoVAC

Axillary pain

2143.8

121

218

44.5

2.3

Vaccination site pain

1980.1

137

242

43.4

3.7

Polymenorrhoea

1474.3

40

101

60.4

2.6

Menstrual disorder

1101.0

108

172

37.2

3.5

Extensive swelling of vaccinated limb

958.9

148

163

9.2

1.5

Lymphadenopathy

937.8

258

433

40.4

1.6

Injection site inflammation

910.1

188

215

12.6

1.2

Menstruation delayed

785.5

42

69

39.1

2.0

Vaccination site reaction

747.1

132

169

21.9

2.7

Myalgia

698.5

193

342

43.6

1.6

Menstruation irregular

506.5

70

89

21.3

1.6

Dysmenorrhoea

501.1

62

98

36.7

1.5

Menorrhagia

445.6

74

100

26.0

1.3

Limb discomfort

393.8

155

330

53.0

1.7

Pericarditis

392.7

246

327

24.8

1.3

Facial paralysis

357.1

257

343

25.1

1.2

Influenza like illness

334.5

184

249

26.1

1.4

Amenorrhoea

324.2

121

138

12.3

1.2

Lethargy

321.0

294

440

33.2

1.4

Myocarditis

318.0

190

280

32.1

1.3

Pyrexia

303.7

447

643

30.5

1.3

Formication

303.2

132

197

33.0

1.3

Headache

295.1

221

387

42.9

1.3

Vaccination site swelling

292.2

166

187

11.2

1.4

Metrorrhagia

278.8

89

99

10.1

1.1

Chills

270.9

283

443

36.1

1.4

Application site pain

263.3

220

294

25.2

2.0

Feeling cold

252.9

229

321

28.7

2.0

Vaccination site erythema

251.0

179

200

10.5

1.5

Fatigue

250.1

315

508

38.0

1.3

Injection site haematoma

240.5

121

145

16.6

1.3

Arthralgia

218.2

284

423

32.9

1.2

Malaise

215.7

249

388

35.8

1.3

Tenderness

200.9

382

416

8.2

1.1

Guillain-Barre syndrome

200.0

264

288

8.3

3.8